This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2020 Sep;19(9):712-713.

doi: 10.1016/S1474-4422(20)30282-9.

Targeting CGRP in migraine: a matter of choice and dose

Linda Al-Hassany¹, Antoinette Maassen Van Den Brink²

Affiliations

Affiliations

¹ Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, Netherlands.
² Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, Netherlands. Electronic address: a.vanharen-maassenvandenbrink@erasmusmc.nl.

PMID: 32822621
DOI: 10.1016/S1474-4422(20)30282-9

Comment

Targeting CGRP in migraine: a matter of choice and dose

Linda Al-Hassany et al. Lancet Neurol. 2020 Sep.

. 2020 Sep;19(9):712-713.

doi: 10.1016/S1474-4422(20)30282-9.

Authors

Linda Al-Hassany¹, Antoinette Maassen Van Den Brink²

Affiliations

¹ Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, Netherlands.
² Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, Netherlands. Electronic address: a.vanharen-maassenvandenbrink@erasmusmc.nl.

PMID: 32822621
DOI: 10.1016/S1474-4422(20)30282-9

No abstract available

PubMed Disclaimer

Comment on

Safety, tolerability, and efficacy of orally administered atogepant for the prevention of episodic migraine in adults: a double-blind, randomised phase 2b/3 trial.
Goadsby PJ, Dodick DW, Ailani J, Trugman JM, Finnegan M, Lu K, Szegedi A. Goadsby PJ, et al. Lancet Neurol. 2020 Sep;19(9):727-737. doi: 10.1016/S1474-4422(20)30234-9. Lancet Neurol. 2020. PMID: 32822633 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program